Coronavirus Disease 2019 in Immunocompromised Organ Transplant Recipients: A Case Report and Review of the Literature

Transplant Proc. 2020 Nov;52(9):2698-2702. doi: 10.1016/j.transproceed.2020.07.014. Epub 2020 Jul 30.

Abstract

Coronavirus disease 2019 (COVID-19) is an ongoing pandemic caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2. Our understanding of this new disease continues to grow. The impact of the disease on immunocompromised transplant recipients is largely unknown. We present a case of a solid organ transplant recipient on immunosuppressive therapy who successfully recovered from COVID-19 infection. We also review 10 similar cases found in the literature and describe the clinical course and management, including immunosuppressive therapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / immunology*
  • Female
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / therapeutic use
  • Pandemics
  • Pneumonia, Viral / immunology*
  • SARS-CoV-2
  • Transplant Recipients*

Substances

  • Immunosuppressive Agents